Back to Gene
RASA1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

RASA1 gene

The RASA1 gene regulates the RAS/MAPK signaling pathway, and its dysfunction is linked to vascular malformations and certain skin cancers.

Normal Function

The RASA1 gene provides instructions for making a protein called p120-RasGAP. This protein helps regulate the RAS/MAPK signaling pathway, which transmits signals from outside the cell to the cell's nucleus. This pathway directs important cell functions, including growth, division (proliferation), maturation (differentiation), and movement.

The p120-RasGAP protein acts as a negative regulator, turning off these signals when they are not needed. It appears to be essential for the normal development of the vascular system, the network of arteries, veins, and capillaries that carry blood.

Health Conditions Related to Genetic Changes

Capillary malformation-arteriovenous malformation syndrome

Several dozen mutations in the RASA1 gene cause capillary malformation-arteriovenous malformation syndrome (CM-AVM), a condition characterized by vascular system abnormalities. Most mutations prevent the production of functional p120-RasGAP protein.

Parkes Weber syndrome

Mutations in the RASA1 gene have been identified in people with Parkes Weber syndrome. Affected individuals typically have multiple capillary malformations, other vascular system abnormalities, and overgrowth of one limb, most commonly a leg.

Cancers

At least three somatic mutations in the RASA1 gene have been detected in basal cell carcinoma, a form of skin cancer. Researchers suspect these mutations lead to a loss of p120-RasGAP function, potentially allowing uncontrolled RAS/MAPK signaling and unregulated cell proliferation.

Other Names for This Gene

  • DKFZp434N071
  • GAP
  • GTPase-activating protein
  • p120
  • p120GAP
  • p120RASGAP
  • ras GTPase-activating protein 1
  • RAS p21 protein activator (GTPase activating protein) 1
  • RASA
  • RASA1_HUMAN
  • RASGAP
  • triphosphatase-activating protein

Genomic Location

The RASA1 gene is found on chromosome 5.

Frequently Asked Questions

Treatment depends on the lesion. Small capillary malformations often need only observation. Larger AVMs may be managed with embolization, surgical resection, or stereotactic radiosurgery. In some cases, sirolimus (an mTOR inhibitor) has shown benefit for complex vascular anomalies, but it is used off‑label and requires specialist supervision.
RASA1 mutations are autosomal‑dominant with about 50 % transmission risk to each child. However, penetrance is variable—some carriers have mild or no symptoms, while others develop significant malformations. Genetic counseling and, if desired, prenatal or pre‑implantation testing can provide reproductive options.
Capillary malformation‑arteriovenous malformation (CM‑AVM) can be associated with fast‑flow lesions such as arteriovenous malformations (AVMs) that may bleed or cause neurologic issues. An MRI/MRA or ultrasound of the area is usually ordered to look for hidden AVMs. Early imaging and regular follow‑up with a vascular specialist help prevent complications.
dults with a known RASA1 mutation should have a baseline clinical skin exam, Doppler ultrasound of the limbs, and brain MRI to detect silent AVMs. Repeat imaging every 3‑5 years, or sooner if new symptoms (headaches, seizures, limb swelling) appear, is recommended.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA